OP Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.84M Buy
122,567
+29,943
+32% +$719K 0.02% 483
2026
Q2
$3.09M Buy
92,624
+5,707
+7% +$142K 0.03% 355
2026
Q1
$1.82M Buy
+86,917
New +$1.96M 0.02% 488

Other funds holding RARE

OP Asset Management's RARE Position: Q3 2026 in Review

OP Asset Management increased its Ultragenyx Pharmaceutical (RARE) stake by 32% in Q3 2026, buying an estimated $719K and bringing the position to 122,567 shares worth $1.84M. The position accounts for 0.02% of the portfolio, ranked #483.

OP Asset Management first reported a position in RARE in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.09M in Q2 2026. 267 funds tracked by Wall St. Rank hold RARE as of Q3 2026.

  • OP Asset Management held 122,567 shares of Ultragenyx Pharmaceutical worth $1.84M as of Q3 2026.
  • OP Asset Management bought 29,943 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $719K.
  • Ultragenyx Pharmaceutical made up 0.02% of OP Asset Management's portfolio in Q3 2026, its #483 holding.
  • OP Asset Management first reported a position in Ultragenyx Pharmaceutical in Q1 2026 and has held it in 3 quarters since.
  • OP Asset Management's Ultragenyx Pharmaceutical position peaked at $3.09M in Q2 2026.
  • 267 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.

Based on OP Asset Management's 13F filing for Q3 2026, filed 5 Nov 2026.